Tulobuterol
Back to searchMolecule Structure
Scientific Name
Tulobuterol
Description of the Drug
Tulobuterol is an inhaled long-acting beta2-adrenergic receptor agonist used as a bronchodilator in the management of asthma and COPD.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12248
http://www.drugbank.ca/drugs/DB12248
Brand Name(s)
Brelomax, Respacal
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL122692 |
| DrugBank | DB12248 |
| PubChem: Thomson Pharma | 14798095 |
| PubChem | 5606 |
| Mcule | MCULE-2223542666 |
| LINCS | LSM-4417 |
| Nikkaji | J16.872F |
| BindingDB | 50421717 |
| EPA CompTox Dashboard | DTXSID7048457 |
| DrugCentral | 2782 |
| ChemicalBook | CB8320201 |
| rxnorm | TULOBUTEROL |
| ChEBI | 93856 |
